Innovus Pharma CEO Provides Shareholder Update and Conference Call
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market: INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases is pleased to provide a shareholder update for First Quarter 2016.Innovus Pharma (INNV): Targeting $3+ Billion Markets with 13 Commercial Products
Most micro- and small-cap biotechnology firms are development-stage opportunities with a lengthy commercialization timeline. For investors, these companies have relatively high risks due to the high costs and uncertainty of regulatory approval.SeeThruEquity Issues Update Note on Innovus Pharmaceuticals, Inc. with a Target Price of $0.80 (OTCBB:INNV)
SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company note on Innovus Pharmaceuticals, Inc. (OTCBB:INNV)